Abstract
During a 1-year period, the prevalence of thymidine-dependent (TD) Staphylococcus aureus in patients at two geographically distinct cystic fibrosis (CF) centers was determined. Of 200 CF patients who had their respiratory secretions cultured, 95 harbored S. aureus, and 20 (21%) had TD S. aureus as their predominant staphylococcal isolate. All 20 TD S. aureus-positive patients had received trimethoprim-sulfamethoxazole for an average of 30.9 months. It was also observed that TD S. aureus exhibited aberrant colony morphologies or did not grow on media commonly used in CF centers for S. aureus isolation, suggesting that this organism could be missed by routine culture methods. In contrast, all 20 isolates had typical staphylococcal morphology on mannitol salt agar after 48 h of incubation. Mannitol salt agar is recommended for primary isolation of TD S. aureus.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gilligan P. H., Gage P. A., Bradshaw L. M., Schidlow D. V., DeCicco B. T. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol. 1985 Jul;22(1):5–8. doi: 10.1128/jcm.22.1.5-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Howden R. A new medium for the isolation of Staphylococcus aureus, including thymine requiring strains, from sputum. Med Lab Sci. 1981 Jan;38(1):29–33. [PubMed] [Google Scholar]
- Kelly H. W., Lovato C. Antibiotic use in cystic fibrosis. Drug Intell Clin Pharm. 1984 Oct;18(10):772–783. doi: 10.1177/106002808401801001. [DOI] [PubMed] [Google Scholar]
- Marks M. I. The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis. J Pediatr. 1981 Feb;98(2):173–179. doi: 10.1016/s0022-3476(81)80631-2. [DOI] [PubMed] [Google Scholar]
- Sabath L. D., Garner C., Wilcox C., Finland M. Susceptibility of Staphylococcus aureus and Staphylococcus epidermidis to 65 antibiotics. Antimicrob Agents Chemother. 1976 Jun;9(6):962–969. doi: 10.1128/aac.9.6.962. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sparham P. D., Lobban D. I., Speller D. C. Isolation of Staphylococcus aureus from sputum in cystic fibrosis. J Clin Pathol. 1978 Oct;31(10):913–918. doi: 10.1136/jcp.31.10.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stokes A., Lacey R. W. Effect of thymidine on activity of trimethoprim and sulphamethoxazole. J Clin Pathol. 1978 Feb;31(2):165–171. doi: 10.1136/jcp.31.2.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Then R. L. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Rev Infect Dis. 1982 Mar-Apr;4(2):261–269. doi: 10.1093/clinids/4.2.261. [DOI] [PubMed] [Google Scholar]
- Wood R. E., Boat T. F., Doershuk C. F. Cystic fibrosis. Am Rev Respir Dis. 1976 Jun;113(6):833–878. doi: 10.1164/arrd.1976.113.6.833. [DOI] [PubMed] [Google Scholar]